What happens after your first Mounjaro pen dose

The decision your first dose is actually asking you to make

The first pen of Mounjaro lands you at a fork. You can read what you feel in that first week as signal or noise. The real question isn't "is this working?", it's "is my body finding its footing?" That distinction shapes everything about how you use the next few months of treatment.

Tirzepatide, the active ingredient in Mounjaro, activates two receptors involved in appetite regulation and blood-sugar control: GIP and GLP-1. The NHS describes this dual mechanism as slowing gastric emptying and increasing the sense of fullness. At 2.5 mg, the dose is deliberately modest. The body isn't encountering the medicine's full therapeutic weight at this stage, it's encountering it for the first time. Think of the first pen as the period where your digestive system learns the rules, not the period where the results arrive.

People respond differently. Some feel very little from the first injection. Others notice nausea, a feeling of fullness after small meals, or some fatigue. Both are within the normal range. What you're looking for is a pattern you can live with, and any concerns about that pattern are best put to your prescriber rather than managed alone. Our support team is available seven days a week if questions come up between consultations.

What side effects after one dose actually look like in practice

The most commonly reported side effects after starting Mounjaro are gastrointestinal: nausea, constipation, loose stools, reflux or indigestion, and burping. These reflect the medicine slowing the movement of food through your stomach, which is also partly why appetite falls. The NHS tirzepatide information page notes that these effects are typically most noticeable when starting treatment or moving to a higher dose, and that they often settle as your body adjusts.

For most people, the worst of it arrives in the two or three days after the injection, then quietens before the next weekly dose is due. Eating smaller portions, avoiding very fatty or rich food, and staying well hydrated all help. None of that is dosing advice, it's the kind of practical adjustment that consistently makes the first few weeks more manageable.

One thing worth knowing: if you experience severe, persistent stomach pain that radiates to the back, seek medical attention promptly. The MHRA's January 2026 Drug Safety Update flagged acute pancreatitis as a known (though infrequent) risk with GLP-1 medicines. It's rare, but it's the symptom that warrants a call to 111 rather than a wait-and-see approach. You can also report any suspected side effect directly through the MHRA's Yellow Card scheme.

Why you won't know if it's working after just one dose

Patience is genuinely hard here. The first pen of Mounjaro arrives (plain box, DPD tracked to your door) and it's natural to want to know immediately whether it's going to make a difference. The honest answer is that one dose doesn't tell you much about results. It tells you about tolerability.

SURMOUNT-1, the pivotal clinical trial published in the New England Journal of Medicine, measured outcomes over 72 weeks. Average weight reduction at the highest doses approached 20–21%. That number accrued over many months and multiple dose increases, not over the first four weeks at 2.5 mg. Understanding what changes dose by dose across the treatment schedule gives a more accurate frame than looking at week one in isolation.

Appetite reduction does often begin to register within the first week or two, that's real, and it's the medicine working as it should. But the scale on the second morning after your first injection is not evidence of anything. The trajectory matters more than any single reading.

What comes next, and who decides

Four weeks after your first dose, you'll be due your second pen, and it can help to read about what most people notice once they've completed two doses. At that point, the decision about whether to stay at 2.5 mg for another month or step up to 5 mg belongs to your prescriber, based on how you've tolerated the starting dose. It's a clinical call, not an automatic one. If side effects were significant, another month at the same dose is often sensible. If things settled quickly and appetite suppression is modest, a step up may be appropriate. You can read more about what the 5 mg dose typically involves if you want to understand what that step looks like.

Repeat orders at nume go through a clinical review before dispatch, not a checkbox, but a prescriber actually reading your update. Many people also find it useful to look ahead at how the treatment tends to feel after a third dose, or to get a longer view by checking what typically shifts for people who have reached their fourth pen. If you have questions about the cost of ongoing treatment, or want to understand the broader treatment pathway before committing, our prescribers are the right people to ask. This is also a good moment to check that Mounjaro is genuinely the right fit, the weight-loss treatment overview covers what's licensed and who it's most suitable for.

If you haven't yet started and are weighing up whether to go ahead, speaking to our prescribers is the first step. There's no pressure to proceed, and the consultation is free.